Prognostic and predictive value of VEGF, sVEGFR-2 and CEA in mCRC studies comparing cediranib, bevacizumab and chemotherapy

BACKGROUND: The prognostic/predictive value of potential vascular endothelial growth factor (VEGF) signalling biomarkers was evaluated retrospectively using samples from two randomized Phase III studies (HORIZON II and III) investigating cediranib in metastatic colorectal cancer (mCRC). METHODS: Bas...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Jürgensmeier, J M, Schmoll, H-J, Robertson, J D, Brooks, L, Taboada, M, Morgan, S R, Wilson, D, Hoff, P M
Materialtyp: Artigo
Språk:Inglês
Publicerad: Nature Publishing Group 2013
Ämnen:
Molecular Diagnostics
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3619270/
https://ncbi.nlm.nih.gov/pubmed/23449351
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2013.79
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk